Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance

Centene CorpTrade
KraneShares Electric Vehicles and Future MobilityTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Centene Corp trades at $66.8 (market cap $33.93B), while KraneShares Electric Vehicles and Future Mobility trades at $30.57. The key difference: Centene Corp is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.

CNCKARS
Market Cap
$33.93B
Sector
HealthSector/Thematic
52-Week High
$68.72$38.01
52-Week Low
$25.21$23.10
Enterprise Value
$26.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

KraneShares Electric Vehicles and Future Mobility

KARS trades at $29.72, down 2.8% in the last 24 hours, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The stock lacks key financial ratio data, but recent news highlights global EV sales growth, particularly in Europe and China, driven by high fuel prices and policy support. However, competition from Chinese automakers and potential US regulatory barriers present challenges.

The outlook for KARS is mixed, with positive industry tailwinds from rising EV adoption offset by technical weakness and competitive risks. Investment opportunities lie in exposure to the expanding EV market, but investors face volatility from geopolitical factors and shifting consumer demand. Caution is warranted given the bearish technical signals and lack of fundamental clarity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About KraneShares Electric Vehicles and Future Mobility

KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.

Read more on KARS